Eli Lilly Expands Gene Therapy Portfolio to Eye Care with $475M MeiraGTx Deal
Eli Lilly bets big on the future of gene therapy for vision restoration. Eli Lilly is making another bold move…
From Latency to Lineages: Reading Viral Signals in the Eye at AAO 2025
At AAO, an OMIG-cosponsored symposium followed viruses from dormancy to disease, showing how genomics, trials and global surveillance are reshaping…
latest posts
